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Abstract
Despite the identiﬁcation of several genetic factors linked to increased susceptibility to inﬂammatory bowel disease (IBD),
underlying molecular mechanisms remain to be elucidated in detail. The ubiquitin ligases RNF20 and RNF40 mediate the
monoubiquitination of histone H2B at lysine 120 (H2Bub1) and were shown to play context-dependent roles in the
development of inﬂammation. Here, we aimed to examine the function of the RNF20/RNF40/H2Bub1 axis in intestinal
inﬂammation in IBD patients and mouse models. For this purpose, intestinal sections from IBD patients were
immunohistochemically stained for H2Bub1. Rnf20 or Rnf40 were conditionally deleted in the mouse intestine and mice
were monitored for inﬂammation-associated symptoms. Using mRNA-seq and chromatin immunoprecipitation (ChIP)-seq,
we analyzed underlying molecular pathways in primary intestinal epithelial cells (IECs) isolated from these animals and
conﬁrmed these ﬁndings in IBD resection specimens using ChIP-seq.The majority (80%) of IBD patients displayed a loss of
H2Bub1 levels in inﬂamed areas and the intestine-speciﬁc deletion of Rnf20 or Rnf40 resulted in spontaneous colorectal
inﬂammation in mice. Consistently, deletion of Rnf20 or Rnf40 promoted IBD-associated gene expression programs,
including deregulation of various IBD risk genes in these animals. Further analysis of murine IECs revealed that H3K4me3
occupancy and transcription of the Vitamin D Receptor (Vdr) gene and VDR target genes is RNF20/40-dependent.
Finally, these effects were conﬁrmed in a subgroup of Crohn’s disease patients which displayed epigenetic and expression
changes in RNF20/40-dependent gene signatures. Our ﬁndings reveal that loss of H2B monoubiquitination
promotes intestinal inﬂammation via decreased VDR activity thereby identifying RNF20 and RNF40 as critical regulators
of IBD.
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Inﬂammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), affects approximately
one individual in 250 Europeans and North Americans [1].
Indeed, rapid increases in the incidence of IBD within
populations strongly suggest an environmental component
to disease susceptibility. One major link between the
exposome and pathophysiology is chromatin modiﬁcations
stably altering transcriptional programs and cellular function [2]. One such epigenetic modiﬁer, the obligate RNF20/
RNF40 heterodimer responsible for H2B monoubiquitination (H2Bub1), has recently been implicated in intestinal
inﬂammation in a context-dependent fashion [3, 4]. A
recent CRISPR screen identiﬁed RNF20 as a negative
modulator of regulatory T cells [5] which play an important
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role in the pathogenesis of IBD [6, 7]. In addition, the
heterozygous global knockout of Rnf20 in mice resulted in
increased inﬁltration of myeloid-derived suppressor
cells [4]. Thus, while the H2B monoubiquitination pathway
is clearly essential for immune regulation, little mechanistic
detail is known about the cell-intrinsic function of RNF20
and RNF40 in IBD.
Generally, the obligate RNF20/RNF40 heterodimer is
recruited by the WW domain-containing adapter protein
with coiled-coil (WAC) to the elongating RNA Polymerase II (RNAPII) following phosphorylation of serine 2
within the C-terminal domain of RNAPII [8]. As an E3
ligase complex, the RNF20/40 dimer monoubiquitinates
histone H2B at lysine 120, an epigenetic mark associated
with increased chromatin accessibility, resulting in eased
passage of RNAPII and highly active transcriptional
elongation [9]. In addition, as supported by studies in
yeast [10, 11] and our own experiments [12], H2Bub1
regulates the trimethylation of histone 3 at lysine 4
(H3K4me3), which is also tightly associated with transcriptional elongation [13]. Epigenetic pathways marked
by H3K4me3 occupancy are emerging as relevant therapeutic targets in IBD patients as evidenced by recent
studies [14, 15].
Besides its role in transcriptional regulation, H2Bub1
was suggested as a potential tumor-suppressive marker in
colorectal cancer (CRC) [16]. Counterintuitively, depletion of RNF20 and RNF40 resulted in reduced tumorigenic potential of CRC cells in vitro, potentially due to
enhanced apoptosis rates [3, 17]. In addition, ablation of
either, RNF20 or RNF40, modulates Nuclear Factor
kappa-light-chain-enhancer of activated B cells (NF-κB)
signaling [3, 4, 18]. However, the consequences of Rnf20
and Rnf40 loss in the context of intestinal inﬂammation
have not been directly compared in the same experimental
settings.
Given the scarce knowledge on the cell-speciﬁc functions of RNF20/RNF40, we sought to investigate the
importance of the H2B monoubiquitination pathway in IBD
through a multidimensional analysis of mouse to human
experimental systems. We detected reduced H2Bub1
amounts in 80% of IBD patients and, accordingly, intestinal
deletion of Rnf20 or Rnf40 resulted in the development of
spontaneous colorectal inﬂammation in mice. Of mechanistic importance, we found Vitamin D Receptor (Vdr) gene
as well as VDR target gene H3K4me3 occupancy and
expression to be highly dependent upon RNF20/40. As
vitamin D status remains one of the few environmental
associations with IBD activity [19], this report provides
unique insight into the epigenetic regulation of this key
IBD-associated factor.
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Results
Loss of H2Bub1 is associated with intestinal
inﬂammation in IBD patients
A previous mouse model of global haploinsufﬁciency of
Rnf20 suggested that the H2B monoubiquitination pathway
may suppress intestinal inﬂammation [4]. However, there is
a lack of knowledge on cell-speciﬁc functions of RNF20
and RNF40 in IBD. To examine a potential cell typespeciﬁc function of these H2B ubiquitin ligases, we
analyzed a recent single cell RNA-seq dataset comparing
cell-speciﬁc transcriptome-wide effects in Crohn’s disease
(CD) patients [20]. Upon clustering of cell types (Fig. 1A),
we detected RNF20 and RNF40 gene expression primarily
within epithelial cells (Fig. 1B). Therefore, to test for a
putative function of the RNF20/40 axis in controlling
intestinal inﬂammation, we studied colon sections of dextran sodium sulfate (DSS)-treated mice by performing
immunohistochemistry for H2Bub1. Interestingly, H2Bub1
was lost in the majority of inﬂamed epithelial areas
(Fig. 1C, D). To evaluate, whether this ﬁnding could be
translated to the human condition, we performed immunohistochemical staining of H2Bub1 in a panel of human
Crohn’s disease samples with corresponding uninﬂamed
adjacent tissue (NAT) from resection margins as a control.
Notably, when quantifying nuclear staining intensity, we
observed a signiﬁcant decrease in H2Bub1 levels in
inﬂamed epithelium (Fig. 1E, F). In fact, when comparing
inﬂamed to healthy tissue within the same individual, we
discovered that 80% of IBD patients displayed a strong
reduction in H2Bub1-positive inﬂamed epithelial cells,
while only 20% of patients displayed no changes in
H2Bub1 levels. The observed association between H2Bub1
deﬁciency and intestinal inﬂammation led us to subsequently investigate the in vivo mechanistic role of RNF20/
40 in the intestinal epithelium.

Genetic deletion of Rnf20 or Rnf40 promotes
spontaneous colorectal inﬂammation
To evaluate the biological and molecular consequences of
H2Bub1 loss in intestinal epithelial cells, we generated
Villin-CreERT2, Rnf20ﬂox, and Villin-CreERT2, Rnf40ﬂox
mice (Fig. 1G). The conditional tamoxifen-inducible deletion of each of the E3 ligases Rnf20 and Rnf40 individually
provided complementary approaches to induce the loss of
H2Bub1 in intestinal epithelial cells. Notably, 14 days after
the ﬁrst tamoxifen injection, Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ mice
already displayed severe weight loss of up to ca. 15%
(Fig. 1H, Supplementary Fig. S1A). Accordingly, the
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Fig. 1 IBD patients display H2Bub1 loss in inﬂamed intestinal
epithelium. A Cell type clustering in a uniform manifold approximation and projection (UMAP) based on scRNA-seq data evaluating
cell-speciﬁc gene expression changes between uninﬂamed and
inﬂamed resection specimens isolated from Crohn’s disease patients
[20]. B Dot plot displaying the expression level and the percentage of
cells within each cell cluster expressing RNF20 and RNF40. RNF20
and RNF40 levels were highest in epithelial cells. C Colon sections of
C57BL/6N mice treated with 0.75% DSS (n = 6) for 14 days were
stained for H2Bub1 using IHC. Relative staining intensity was quantiﬁed using FIJI in ﬁve images per mouse. D Representative images of
murine colon sections displaying reduced H2Bub1 levels in inﬂamed
epithelium. Scale bar: 100 μm. E Intestinal sections of Crohn’s disease
patients (n = 18) were stained for H2Bub1 using IHC. Relative

staining intensity was quantiﬁed using FIJI in ﬁve images per patient.
When comparing healthy resection margins to inﬂamed tissue, 80% of
patients displayed reduced H2Bub1 levels in inﬂamed regions.
F Representative images of colon sections of two IBD patients stained
for H2Bub1. Scale bar: 100 μm. G Mice with loxP-ﬂanked exons 3–5
of Rnf20 or loxP-ﬂanked exons 3–4 of Rnf40 were mated with VillinCreERT2 mice to enable a tamoxifen-inducible intestinal knockout of
Rnf20 or Rnf40, respectively. H Fourteen days after the ﬁrst tamoxifen
injection, Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ mice displayed severe weight loss and,
therefore, (I) signiﬁcantly reduced survival (red dotted line represents
start of tamoxifen treatment). Survival data were based on local and
institutional guidelines according to which animals needed to be
sacriﬁced after a weight loss of 20%. One-way ANOVA, mean ±
SEM.

Disease Activity Index (DAI) was elevated in these animals
(Supplementary Fig. S1B-E). As a consequence of high
disease activity, Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ mice displayed signiﬁcantly decreased survival compared to wild type and
heterozygous litter mates (Fig. 1I).
Consistent with an increased DAI and reduced survival,
mice with an intestinal deletion of Rnf20 or Rnf40 displayed
signiﬁcantly decreased colon length (Fig. 2A, Supplementary Fig. S1F, G). After conﬁrming the successful loss of
H2Bub1, RNF20, and RNF40 in Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ
animals (Fig. 2B, Supplementary Fig. S1H), H&E staining

of the colon revealed severe epithelial damage in Rnf20- and
Rnf40-deﬁcient mice (Fig. 2C). The colorectal epithelial
damage was quantiﬁed by determination of the H-score, a
scoring system based on the intactness of the colonic epithelium and lymphocyte inﬁltration. Indeed, Rnf20ﬂ/ﬂ and
Rnf40ﬂ/ﬂ mice displayed a high degree of epithelial damage
and lymphoid inﬁltrates, contributing to a signiﬁcantly
increased H-score (Fig. 2D, E; Supplementary Fig. S1I).
Consistently, we observed increased inﬁltration of CD45positive immune cells (Fig. 2F, G) and increased vascularization (Supplementary Fig. S1J, K) in these animals while
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Fig. 2 Intestinal Rnf20 and
Rnf40 deletion results in
spontaneous colorectal
inﬂammation in mice. A
Homozygous Rnf20 or Rnf40
deletion resulted in decreased
colon length. B The knockout
efﬁciency in Rnf20ﬂ/ﬂ and
Rnf40ﬂ/ﬂ mice was demonstrated
using IHC for H2Bub1 on colon
sections. C Colons were H&Estained and (D) the percentage
of segments with mild [1],
medium [2], or severe [3]
epithelial damage was
determined. Rnf20 and Rnf40
intestine-speciﬁc knockout mice
displayed more areas with
epithelial damage than wildtype
or heterozygous animals.
E Based on the damage, the
H score was calculated and
shown to be elevated upon the
loss of Rnf20 and Rnf40. F IHC
for CD45-positive cells in the
colon revealed (G) increased
inﬁltration of immunoregulatory
cells. Scale bar: 100 μm. Oneway ANOVA, mean ± SEM.

only minor effects were observed on serum IL-6 levels
(Supplementary Fig. S1L). In summary, the Villin-CreERT2mediated deletion of Rnf20 or Rnf40 promotes spontaneous
colorectal inﬂammation in mice. In contrast, mice heterozygous for Rnf20 or Rnf40 deletion did not develop spontaneous inﬂammation (Supplementary Fig. S2) and did not
display increased sensitivity to DSS-mediated colitis (Supplementary Fig. S3). These results suggest that only a
complete loss of Rnf20 and Rnf40, and therefore H2Bub1, is
sufﬁcient to induce spontaneous colorectal inﬂammation.

Rnf20/40 deletion promotes IBD-associated gene
expression programs
To gain initial insight into the molecular mechanisms by
which perturbation of the H2B monoubiquitination axis
leads to intestinal inﬂammation, we examined transcriptomewide changes in intestinal epithelial cells (IECs) directly
isolated from the colons of Villin-CreERT2, Rnf20ﬂ/ﬂ and
Rnf40ﬂ/ﬂ mice and compared these to wild type controls
14 days after tamoxifen injection. After conﬁrming the loss
of Rnf20 and Rnf40 expression at the mRNA and protein
level as well as the loss of H2Bub1 (Fig. 3A, B), we

performed mRNA-seq. As expected, Rnf20 and Rnf40
deletion resulted in the differential regulation of a broad
variety of genes (Fig. 3C). Gene subsets were divided into
three clusters (upregulated in wild type, Rnf20ﬂ/ﬂ or Rnf40ﬂ/ﬂ,
respectively) and analyzed for pathway enrichment using
Enrichr [21, 22]. Interestingly, factors involved in Oglycosylation of mucins and other proteins were commonly downregulated upon loss of Rnf20 or Rnf40. While
many processes were commonly enriched following deletion
of either H2B ubiquitin ligase, Rnf20ﬂ/ﬂ IECs demonstrated a
higher enrichment of gene sets related to cytokine signaling
and epidermal differentiation while Rnf40ﬂ/ﬂ cells showed an
enrichment of ribosome biogenesis and gene expressionrelated processes (Fig. 3D). Finally, we sought to determine
whether gene expression patterns altered following Rnf20
and Rnf40 deletion in IECs may be relevant for murine
models for colitis and human IBD. Indeed, we found that
genes related to inﬂamed tissue in DSS-treated mice [23] as
well as in patients with severe IBD [24] were enriched in
Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ IECs (Fig. 3E). Thus, the intestinal
deletion of Rnf20 and Rnf40 in murine IECs is associated
with gene expression proﬁles induced in murine and human
intestinal inﬂammation.
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Fig. 3 The intestinal loss of either Rnf20 or Rnf40 drives IBDassociated transcriptome-wide changes. A The loss of Rnf20 or
Rnf40 in IECs was conﬁrmed at the mRNA and (B) protein levels
using qRT-PCR and western blot, respectively. C mRNA-seq was
performed using wild type, Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ IECs (n = 2).
Heatmap depicting the transcriptome-wide effects of Rnf20 and Rnf40
deletion by showing signiﬁcantly (padj ≤ 0.05) upregulated (log2 FC ≥
1, red) or downregulated (log2 FC ≤ −1, blue) genes. D Based on
expression patterns, genes were divided into three clusters which were

analyzed using gene ontology (Enrichr) [21, 22]. Genes enriched in
wild type controls were associated with O-glycosylation while genes
enriched in Rnf20 and Rnf40 knockout mice correlated with cytokinemediated signaling and gene expression processes, respectively.
E Differentially regulated genes upon Rnf20 and Rnf40 knockout in
IECs were compared to previously published gene expression signatures [23, 24] using GSEA. Transcriptional changes associated with
DSS-induced colitis in mice as well as severe IBD were enriched in
Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ IECs. One-way ANOVA, mean ± SEM.

RNF20 and RNF40 are required for the expression of
IBD susceptibility genes

occupancy in the gene body with only marginal effects
closer to the TSS (Fig. 4A). Focusing on this discovery, we
closely examined the genes displaying RNF20/40-dependent changes in H3K4me3 occupancy and decreased
expression. Given the inﬂammatory consequences of an
intestine-speciﬁc Rnf20/40 deletion in mice, we performed
an enrichment analysis of the RNF20/40-dependent genes
with published IBD susceptibility gene lists [27, 28].
Remarkably, 19% of published IBD susceptibility genes
appeared to be regulated by this RNF20/RNF40/H3K4me3dependent mechanism (Fig. 4B). Consistently, a downregulation of those IBD susceptibility genes at the mRNA
level could be conﬁrmed in our mRNA-seq data (Fig. 4C).
In summary, these ﬁndings reveal a previously unknown
function of RNF20/40 in regulating H3K4me3 occupancy
and gene expression of a high proportion of IBD susceptibility genes.

Early studies exploring the molecular function of H2Bub1
revealed that this epigenetic mark is highly enriched across
the transcribed region of active genes [25]. Mechanistically,
H2Bub1 enables RNAPII passage through chromatin [26].
H2Bub1 also facilitates deposition of H3K4me3 in yeast
[10, 11]. The histone modiﬁcation H3K4me3 is an established mark of actively transcribed transcription start sites
(TSS) and gene bodies. Indeed, our prior work substantiated
a role for H2Bub1 in elongation-associated spreading of
H3K4me3 into the gene body of RNF40-dependent genes
[12]. Thus, we performed ChIP-seq in IECs to analyze
H3K4me3 occupancy upon the deletion of Rnf20 and
Rnf40. Consistent with our prior work, loss of Rnf20 or
Rnf40 resulted in a signiﬁcant reduction of H3K4me3
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Fig. 4 Loss of RNF20 or RNF40 causes reduced H3K4me3 occupancy on IBD risk genes including Vdr. A Average binding proﬁles
and heatmaps depicting occupancy (RPKM values) of H3K4me3
around the TSS ( ± 5 kb) of genes upregulated, unregulated and
downregulated in wild type, Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ IECs. Genes were
sorted high to low based on H3K4me3 occupancy under wild type
conditions. Binding proﬁles revealed decreased H3K4me3 occupancy
speciﬁcally in the gene body after Rnf20 or Rnf40 loss leading to peak
narrowing. B Genes which lost H3K4me3 occupancy in Rnf20ﬂ/ﬂ and
Rnf40ﬂ/ﬂ IECs were compared for overlap with IBD susceptibility
genes [27, 28] expressed in IECs. H3K4me3 occupancy of 19% of
IBD risk genes is dependent on RNF20 and/or RNF40. C Heatmap
depicting gene expression patterns of a subset of IBD susceptibility
genes in wild type, Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ IECs (padj ≤ 0.05, red:
upregulated (log2 FC ≥ 1), blue: downregulated (log2 FC ≤ −1)).

D Regions that lost H3K4me3 occupancy in Rnf20 and Rnf40 null
IECs were compared to previously published ChIP-seq experiments
using ChIP Atlas (http://chip-atlas.org) displaying a high overlap
between our datasets and VDR-bound regions in the murine small
intestine (SI) [29]. E By analyzing publicly available VDR ChIP-seq
data, VDR-bound regions in murine SI were identiﬁed (75,303
regions) [29] and compared to regions displaying decreased H3K4me3
occupancy in Rnf20 (1,019 regions) and Rnf40 (2,128 regions)
knockout IECs. 79.8% (813/1,019 regions) of Rnf20- and 77.6%
(1,651/2,128 regions) of Rnf40-dependent H3K4me3 regions were
also occupied by VDR. F Binding proﬁles of VDR in SI [29] and
H3K4me3 in IECs revealed H3K4me3 peak narrowing under Rnf20 or
Rnf40 knockout conditions. G Reduced H3K4me3 occupancy in the
Vdr gene body in Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ IECs was conﬁrmed by ChIPqPCR (n = 4). One-way ANOVA, mean ± SEM.

H3K4me3 occupancy on Vdr and VDR target genes is
RNF20- and RNF40-dependent

displayed a particular enrichment on these genes using
occupancy data from publically available ChIP-seq datasets
using ChIP Atlas (http://chip-atlas.org). Intriguingly, we
found Vitamin D Receptor (VDR)-bound regions [29]
(small intestine, mouse, Fig. 4D, E) to be signiﬁcantly
enriched within our dataset. Validating our bioinformatic

In order to uncover further upstream regulatory mechanisms
controlling the expression of RNF20/40-dependent genes in
IEC, we examined whether speciﬁc transcription factors

RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inﬂammatory bowel disease
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Fig. 5 RNF20 and RNF40 are required for transcriptional
elongation-associated H3K4me3 spreading on VDR target genes.
A Venn diagram displaying the overlap between vitamin D-induced
genes [29], genes downregulated following Rnf20 or Rnf40 knockout
in IECs identiﬁed by mRNA-seq and VDR-dependent genes displaying reduced H3K4me3 occupancy upon Rnf20 or Rnf40 deletion in
IECs (upper panel). Numbers marked in red were overlapped to
identify VDR- and RNF20/40-dependent genes with reduced
H3K4me3 occupancy (lower panel). B Enrichr gene ontology analysis

of these 112 genes revealed their involvement in O-linked glycosylation and sulfonation of proteins. C–E ChIP-seq tracks of three
exemplary genes (Abcb1a, Tspan3, Galnt10) illustrated H3K4me3
peak narrowing in Rnf20 and Rnf40 knockout IECs and VDR occupancy in murine small intestine [29]. F ChIP-qPCR for Abcb1a,
Tspan3 and Galnt10 was performed using primers complementary to
the peak summit, in the transcribed region and a negative control site.
Upon Rnf20 and Rnf40 deletion, occupancy in the transcribed region
was signiﬁcantly decreased (n = 4). One-way ANOVA, mean ± SEM.

methodology, the Vdr gene itself was bound by VDR and
displayed profound H3K4me3 peak narrowing following
the loss of Rnf20 or Rnf40 (Fig. 4F). This ﬁnding was
further conﬁrmed using ChIP-qPCR, where a signiﬁcant
reduction of H3K4me3 occupancy was observed in the
transcribed region of the Vdr gene (Fig. 4G). To obtain
further insight into the relationship between RNF20/40- and
VDR-dependent gene regulation, genes induced in the small
intestine of vitamin D-treated mice [29] were overlapped
with genes downregulated upon Rnf20 or Rnf40 loss
(mRNA-seq) and genes which displayed decreased

H3K4me3 occupancy in Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ IECs (ChIPseq). Genes commonly regulated by vitamin D, RNF20, and
RNF40 included several IBD susceptibility genes as well as
mucin-modifying factors (Fig. 5A, B). Indeed, ChIP-seq
tracks (Fig. 5C-E) and ChIP-qPCR (Fig. 5F) conﬁrmed
that these genes displayed reduced H3K4me3 occupancy
speciﬁcally in their transcribed regions. Together, using
corroborating methodology, these results indicate that
RNF20 and RNF40 loss reduces H3K4me3 occupancy on
the IBD susceptibility gene Vdr as well as VDR target
genes.
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Fig. 6 RNF20 and RNF40 deﬁciency results in reduced VDR
levels. A Rnf20 and Rnf40 deletion reduced Vdr mRNA and (B)
protein levels in IECs as demonstrated by qRT-PCR and Western blot.
C IECs were isolated from wild type mice and cultured under vitamin
D-deﬁcient conditions. RNF20 and RNF40 were transiently depleted
using siRNA and 24 h after knockdown cells were treated with calcitriol (1 μM) for 48 h (n = 3). D Calcitriol treatment induced the

mRNA expression of VDR target genes in control cells but not in
RNF20- and RNF40-depleted IECs as detected using qRT-PCR. E The
reduction of Vdr following Rnf20 and Rnf40 genetic deletion was
conﬁrmed in whole colon lysates using qRT-PCR (n = 6). F IHC for
VDR and subsequent (G) determination of staining intensity using FIJI
veriﬁed reduced VDR protein amounts in Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ
colons. Scale bar: 100 μm. One-way ANOVA, mean ± SEM.

The IBD risk gene Vdr is downregulated upon Rnf20
or Rnf40 deletion

VDR gene targets by modulating H3K4 trimethylation and
target gene transcription.
Next, we directly tested this mechanism through a
reductionist in vitro approach. As our results were based on
a vitamin D-proﬁcient mouse model, we aimed to verify our
hypothesis that RNF20 and RNF40 are required to promote
expression of Vdr and VDR target genes in another system.
Thus, we isolated IECs from wild type animals and grew
them in 2D cell culture under vitamin D-deﬁcient conditions. Cells were transfected with siRNAs to transiently
deplete RNF20 and RNF40 and were treated with calcitriol,
the active form of vitamin D. Notably, the induction of Vdr
and VDR target gene expression upon vitamin D treatment
was signiﬁcantly impaired following RNF20 or RNF40

We observed that the IBD susceptibility gene Vdr encoding
the vitamin D receptor was downregulated in our mRNAseq data and, indeed, we conﬁrmed this ﬁnding in IECs at
the mRNA and protein levels (Fig. 6A, B). Accordingly, the
expression of VDR target genes was also signiﬁcantly
reduced in Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ IECs (Supplementary Fig.
S4A). Notably, the overexpression of human VDR in IECs
rescued the downregulation of Vdr as well as VDRdependent genes upon the depletion of RNF20 and RNF40
(Supplementary Fig. S4B-C). Thus, multiple independent
methodologies support that RNF20/40 regulates Vdr and

RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inﬂammatory bowel disease
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Fig. 7 RNF20/40-dependent genes are deregulated in a subset of
IBD patients. A Principal component analysis demonstrating the
separation of IBD patients (n = 30) displaying low (in blue) or high (in
red) expression of RNF20/40-regulated genes detected by mRNA-seq
in murine IECs. B Heatmap displaying the expression of genes differentially marked with H3K27ac between a subset of IBD patients
with markedly low (n = 5) or high (n = 4) expression of RNF20/40dependent genes. C Venn diagram showing the overlap between genes

differentially bound by H3K27ac in IBD patients showing low or high
expression of RNF20/40-regulated genes and genes which have lost
H3K4me3 occupancy in Rnf20/40ﬂ/ﬂ IECs. D Example occupancy
proﬁles of H3K27ac on VDR, ABCB1, and TSPAN3 revealed
decreased H3K27ac occupancy in enhancer and promoter regions in
IBD patients with low (blue) compared to high (red) expression of
RNF20/40-dependent genes.

depletion (Fig. 6C, D). We further conﬁrmed the reduction
of Vdr and VDR target genes in whole colon lysates
isolated from Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ mice at the mRNA
level (Fig. 6E, Supplementary Fig. S5A). Finally, we were
able to verify that VDR protein levels and those of one of its
targets were decreased upon Rnf20 and Rnf40 knockout
via IHC on colon sections (Fig. 6F, G, Supplementary
Fig. S5B, C).

pathway, a subgroup of individuals displayed consistently
low expression for the majority of genes downregulated in
Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ IECs (Fig. 7A, B). Next, genes differentially marked with H3K27ac between patients with low
and high expression of RNF20/40-dependent genes were
overlapped with genes which lost H3K4me3 occupancy in
Rnf20ﬂ/ﬂ and Rnf40ﬂ/ﬂ IECs. Intriguingly, 45% of genes
differentially marked by H3K27ac in IBD patients also
displayed decreased H3K4me3 in Rnf20/40-deﬁcient IECs
(Fig. 7C). Indeed, patients with low expression of RNF20/
40-dependent genes displayed reduced H3K27ac occupancy
on the IBD risk gene VDR as well as VDR targets such as
ABCB1 and TSPAN3 (Fig. 7D). Notably, these patient
subsets did not display differences in serum vitamin D
levels, similar to the situation observed in our mouse model
(Supplementary Fig. S5D, E). Together, our ﬁndings
demonstrate that RNF20 and RNF40 not only regulate the
IBD susceptibility gene VDR but also a high proportion of
VDR target genes in mice. Importantly, we identiﬁed a
subset of IBD patients that displays deregulated expression
and epigenetic marking of RNF20/40-dependent VDR
targets.

A subgroup of CD patients displays deregulation of
RNF20/40-dependent gene signatures
We have demonstrated that intestinal Rnf20 and Rnf40
deletion results in spontaneous colorectal inﬂammation in
mice as well as reduced levels of Vdr and its target genes.
Given the established association of Vitamin D biology as a
risk factor to Crohn’s disease activity, a cohort of CD
patients was analyzed for gene expression and H3K27ac
occupancy. We utilized an emerging methodology of RNA/
chromatin extraction from FFPE tissue from terminal ileal
resection specimens isolated from a well characterized
cohort of CD patients. Conﬁrming the importance of this
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Discussion
Our ﬁndings uncover a novel role for RNF20 and RNF40 in
maintaining Vdr and VDR target gene expression and
suppression of intestinal inﬂammation. While decreased
H2Bub1 levels have been linked to tumor progression and
poor survival in several cancer entities, including CRC [16],
we report for the ﬁrst time that H2B monoubiquitination is
reduced in inﬂamed areas in 80% of Crohn’s disease
patients. In support of this ﬁnding, we observed that complete intestine-speciﬁc ablation of Rnf20 or Rnf40, the genes
encoding the E3 ligases mediating H2B monoubiquitination, promotes spontaneous intestinal inﬂammation in mice.
Molecularly, our ﬁndings demonstrate that RNF20/40 loss
leads to a global narrowing of H3K4me3 peaks, especially
on VDR-dependent genes.
Vitamin D is thought to be an important factor in the
development and perpetuation of IBD, particularly CD [30].
For example, vitamin D deﬁciency in IBD patients has been
described in several studies and was associated with
increased disease activity [19]. These ﬁndings were conﬁrmed in an Il10 knockout-based experimental model for
murine colitis and, indeed, vitamin D supplementation
ameliorated disease activity and reduced mortality [31]. The
biological activity of vitamin D is mediated by the binding
of its active metabolite 1,25-dihydroxyvitamin D3 (1,25
(OH)2D3; calcitriol) to the vitamin D receptor [32]. Intriguingly, VDR gene polymorphisms have also been described to increase IBD susceptibility [33, 34] and VDR levels
were found to be profoundly reduced in inﬂamed colonic
biopsies isolated from IBD patients compared to healthy
controls. Accordingly, the deletion of Vdr in gut epithelial
cells resulted in severe intestinal inﬂammation in chemically
induced colitis in mice while elevated Vdr expression protected animals from symptoms [35]. Despite these ﬁndings
supporting an important role of vitamin D receptor activity
in IBD, environmental or epigenetic modiﬁers regulating
this pathway remained to be elucidated.
As originally shown in yeast [10, 11] and supported by
our previous studies [12], H2B monoubiquitination regulates H3K4me3, an epigenetic mark associated with
increased transcription elongation rates [13]. Consistently,
the loss of H2Bub1 following intestinal Rnf20 or Rnf40
deletion resulted in decreased H3K4me3 occupancy in the
transcribed region of various IBD-associated genes. Notably, upon H2Bub1 loss, we observed H3K4me3 narrowing
on the Vdr gene as well as decreased Vdr mRNA and
protein amounts. Consequently, the induction of VDRdependent gene expression was also impaired. Several of
these common RNF20/RNF40/VDR targets were shown to
be downregulated in experimental colitis, such as Muc2
[36]. This ﬁnding is in agreement with our recent publication describing that H2Bub1 controls early stages of
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osteoblast differentiation and bone cell crosstalk by regulating the expression of the VDR target gene Tnfsf11 [37].
In general, the ﬁnding that VDR-dependent genes are frequently downregulated in IBD supports vitamin D supplementation in clinical practice as well as experimental trials.
Whether the presence of H2Bub1 may potentially serve as a
predictive biomarker for vitamin D responsiveness in IBD
patients remains to be elucidated. However, the observation
that neither Rnf20/40-deﬁcient mice, nor patients with low
expression of RNF20/40-dependent genes displayed vitamin D deﬁciency suggests that vitamin D supplementation
alone would likely not be sufﬁcient to compensate for
decreased vitamin D receptor levels.
Despite the common deregulation of Vdr and VDR target
genes, our mRNA-seq data demonstrate that some genes are
differentially affected by the deletion of Rnf20 and Rnf40 in
IECs. This ﬁnding suggests that RNF20 and RNF40 may
have additional, unique ubiquitination targets in addition to
H2B involved in the regulation of gene expression. Future
mass spectrometry-based identiﬁcation of ubiquitinated
proteins in the presence or absence of RNF20/40 is needed
to clarify the distinct functions of RNF20 and RNF40.
Interestingly, the role of H2Bub1 in controlling intestinal
inﬂammation appears to be dramatically different depending upon the degree to which it is lost. In a previous study,
we employed a different conditional knockout model for the
distal intestinal epithelium (CAC-Cre) which results in a
low knockout efﬁciency [38]. Using this model to delete
Rnf40 resulted in a sporadic loss of RNF40 and
H2Bub1 staining in only 15% of colorectal epithelial cells
and paradoxically elicited a protective effect during DSSinduced colitis. This ﬁnding is in agreement with the current
study in which the inefﬁcient reduction of Rnf20 or Rnf40 in
heterozygous animals did not promote colorectal inﬂammation. Notably, when evaluating why heterozygous mice
only displayed minor differences when compared to wildtype controls, we detected that H2Bub1 staining intensity
was similar across wild-type and heterozygous genotypes.
Thus, we hypothesize that only a complete loss of H2Bub1
in the intestinal epithelium is sufﬁcient to elicit spontaneous
colitis.
The H2B monoubiquitination pathway likely plays
multiple roles in controlling IBD in different cell types.
Interestingly, a recent CRISPR screen identiﬁed RNF20 as a
negative regulator of the master regulatory T cell (Treg)
transcription factor Forkhead box P3 (FOXP3) [5]. In fact,
FOXP3-positive Tregs play an important role in IBD [6, 7].
Similar divergent cell type-dependent differential functions
of an epigenetic regulator in IBD have been demonstrated
for the Polycomb Repressive Complex-2 methyltransferase
component EZH2. In this case, while global inhibition of
EZH2 activity or myeloid-speciﬁc Ezh2 deletion ameliorates experimental intestinal inﬂammation [39] the loss of
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Ezh2 in either the intestinal epithelium [15] or regulatory
T cells [7] results in a spontaneous colitis phenotype. Thus,
when considering the H2B monoubiquitination pathway as
a potential therapeutic target in IBD, it will be essential to
determine and consider the differential roles it plays in
diverse cell types important for IBD biology.
In conclusion, this work describes a previously unknown
role of RNF20/40-mediated H2B monoubiquitination in the
establishment of broad H3K4me3 domains, which appear to
promote the transcriptional elongation of VDR-dependent
genes associated with intestinal inﬂammation. In vivo
experiments revealed that H2Bub1-deﬁcient mice developed spontaneous colorectal inﬂammation and, in support
of these ﬁndings, we detected that 80% of IBD patients
displayed a loss of H2Bub1 in inﬂamed areas. Notably, we
detected a subgroup of IBD patients who display deregulated expression and epigenetic control of RNF20/40dependent gene signatures affecting VDR and VDR target
genes. Based on this, additional studies will be essential to
uncover the interdependence of VDR activity and H2B
monoubiquitination and determine the potential therapeutic
utility of targeting these for the beneﬁt of patients with IBD.

Methods
Patient work
To evaluate H2Bub1 levels in IBD sections, resection
specimens of 18 Crohn’s disease patients (Supplementary
Table S1) were analyzed with approval of the local ethics
committee of the University Medical Center Goettingen,
Germany (registration number: 1/10/19). For each patient,
inﬂamed epithelium, as well as healthy resection margins,
were assessed. Moreover, H3K27ac occupancy was analyzed in resection specimens of 30 Crohn’s disease patients
using chromatin immunoprecipitation (ChIP) as approved
by the local ethics committee of the Mayo Clinic, Rochester, MN, USA (Supplementary Table S2; registration
number: IRB #18-002942). All research was performed in
accordance with the principles expressed in the Declaration
of Helsinki, all study participants voluntarily participated in
the study and gave informed consent.
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recombinase (C57BL/6 N(Cag-FlpO)1Afst/Mmcd) [40].
The Rnf40ﬂox mouse line with loxP sites ﬂanking exons 3–4
was described previously[12]. Both Rnf20ﬂox and Rnf40ﬂox
lines were crossed with Villin-CreERT2 [41] in a C57BL/6
N background to achieve tamoxifen-inducible intestinal
deletion of ﬂoxed Rnf20 or Rnf40 alleles. For knockout
induction, mice were intraperitoneally injected with a dose
of 1 mg tamoxifen (Sigma-Aldrich Co., St. Louis, USA)
per day for 5 consecutive days at the age of 6 weeks.
Numbers of mice sacriﬁced 14 days after the ﬁrst tamoxifen
injection were n = 10 (Rnf20/40wt/wt), n = 7 (Rnf20wt/ﬂ),
n = 8 (Rnf20ﬂ/ﬂ), n = 7 (Rnf40wt/ﬂ), n = 17 (Rnf40ﬂ/ﬂ) and
mice observed over a period of 6 months n = 8 (Rnf20/40wt/wt),
n = 10 (Rnf20wt/ﬂ), n = 7 (Rnf40wt/ﬂ). To induce acute
colitis, animals were treated with 0.75% dextran sodium
sulfate (DSS; MO Biomedicals, LLC, Illkirch, France) for
14 consecutive days as previously described [3] (n = 9
(Rnf20/40wt/wt), n = 10 (Rnf20wt/ﬂ), n = 7 (Rnf40wt/ﬂ)).

Mouse genotyping
DNA was isolated using a Mouse Direct PCR Kit (Stratech
Scientiﬁc, Ely, UK). Upon an initial denaturation step at
94 °C for 2 min, DNA fragments were ampliﬁed as follows:
34 cycles of 94 °C for 20 s, 58 °C for 30 s and 72 °C for 1
min (Rnf20); 34 cycles of 94 °C for 20 s, 62 °C for 30 s and
72 °C for 1 min (Rnf40); 34 cycles of 94 °C for 20 s, 56 °C
for 30 s and 72 °C for 1 min (Cre-recombinase) with a ﬁnal
elongation at 72 °C for 5 min. Primer sequences are listed in
Supplementary Table S3. Fragments were subsequently
analyzed by agarose gel electrophoresis.

Determination of the Disease Activity Index (DAI)
To monitor health condition of mice, the DAI was calculated as previously described [3]. Brieﬂy, the DAI includes
scores for weight loss (0: 0–1%; 1: 1–5%; 2: 5–10%; 3:
10–15%; 4: >15%), stool consistency (0: normal; 1: soft; 2:
very soft; 3: diarrhea) and the presence of occult blood as
determined using the stool guaiac test (0: no blue staining;
1: weak/sporadic staining; 2: medium staining; 3: strong
blue staining; 4: bloody anus). Investigators were blinded
during mouse handling including the determination of the
disease activity index.

Animal work
Isolation of intestinal epithelial cells (IECs)
The Rnf20tm1c(EUCOMM)Wtsi mouse line, referred to here as
Rnf20ﬂox, containing loxP sites ﬂanking exons 3–5 was
generated from the mouse embryonic stem cell line G11
(EPD0701_3_G11) purchased from the European Conditional Mouse Mutagenesis Program (EUCOMM) by crossing “knockout ﬁrst” allele (Rnf20tm1a(EUCOMM)Wtsi) mice
with a mouse line ubiquitously expressing the Flp

Upon sacriﬁcing Villin-CreERT2, Rnf20/40wt/wt, Rnf20ﬂ/ﬂ
and Rnf40ﬂ/ﬂ mice fourteen days upon the ﬁrst tamoxifen
injection, colons were isolated (n = 3 pooled/genotype) and
ﬂushed with ice-cold PBS. Colons were opened longitudinally and washed in ice-cold PBS. A total of <1 mm²
fragments were incubated with collagenase type I (GIBCO®,
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Invitrogen GmbH, Darmstadt, Germany) solution 2 mg/ml
collagenase in washing medium (DMEM/F12 + HEPES
supplemented with 10% fetal bovine serum (FBS), 100
units/ml penicillin, and 100 μg/ml streptomycin) at 37 °C
for approximately 30–40 min. Suspensions were pipetted
vigorously up and down until 50–80% of the crypts were
separated from the muscle layer. Next, suspensions were
transferred to tubes containing 10 ml washing medium.
Upon centrifugation at 250 x g for 5 min, supernatants
containing muscle fragments were aspirated and the cell
pellets were re-suspended in 10 ml washing medium. For
subsequent RNA, ChIP and protein analyses, IEC pellets
were snap-frozen in liquid nitrogen and stored at −150 °C.
For cell culture experiments, wild type IECs were resuspended in growth medium.

IEC cell culture and transfections
IECs were grown in Dulbecco’s Modiﬁed Eagle Medium
(DMEM) supplemented with 20% FBS, 100 units/ml
penicillin and 100 μg/ml streptomycin at 37 °C and 5%
CO2. To transiently deplete RNF20 and RNF40, siRNA
(GE Dharmacon siGENOME; non-targeting siRNA 5 [D001210-05-20], RNF20 siRNAs (D-041733-01, −02, −03,
−04), RNF40 siRNAs (D-059014-01, −02, −03, −04))
transfections were performed using Lipofectamine® RNAiMAX (Invitrogen GmbH, Karlsruhe, Germany) according
to the manufacturer’s instructions. After 24 h, cells were
treated with 1 μM calcitriol (Biomol, Hamburg, Germany),
the active form of vitamin D, dissolved in DMSO or DMSO
alone for 48 h. For VDR overexpression, IECs were transfected with a VDR-eGFP expression plasmid [42] or a
control plasmid using Lipofectamine® 2000 (Invitrogen
GmbH, Karlsruhe, Germany) according to the manufacturer’s instructions. Plasmids were a kind gift from Rajiv
Kumar and Theodore A. Craig (Department of Internal
Medicine, Division of Nephrology and Hypertension, Mayo
Clinic, Rochester, MN). Forty-eight hours after transfection,
siRNAs were added and 72 hours after knockdown, RNA
was isolated. Overexpression of VDR was veriﬁed by qRTPCR and subsequent agarose gel electrophoresis.

Histology and determination of the Histo-score (Hscore)
Hematoxylin and Eosin (H&E) staining and immunohistochemical (IHC) staining of parafﬁn sections were performed
as previously described [3, 43]. Antibodies utilized for IHC
are listed in Supplementary Table S4. To determine
inﬂammation intensity, the H-score was determined on
H&E-stained colon sections as previously described [3]. It
ranges from 0 to 3, considering normal epithelium (0), as
well as intestinal areas displaying mild [1], medium [2], or
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severe [3] epithelial damage. Investigators were blinded
during the analysis of the H-score and IHC stainings.

Western blotting and quantitative real-time PCR
(qRT-PCR)
Protein isolation, western blot analysis, RNA extraction,
reverse transcription, and qRT-PCR were performed as previously described [17]. Gene expression levels were assessed
and normalized to the housekeeping gene Rplp0. Primary
antibodies for western blot and primers for qRT-PCR are
listed in Supplementary Tables S4 and S5, respectively.

mRNA-seq and analysis
mRNA sequencing libraries were prepared using the TruSeq
RNA Library Prep V2 kit (Illumina®) and sequencing was
performed on a HiSeq4000 (Illumina®) at the Genome
Analysis Core, Mayo Clinic as reported earlier [43]. Fastq
ﬁles were mapped to the mouse reference genome mm9 and
analysis was performed as previously described [43]. All
data have been deposited at ArrayExpress (http://www.ebi.
ac.uk/arrayexpress, accession number: E-MTAB-9405).
Gene set enrichment analysis (GSEA) [44, 45] was performed using custom gene sets containing genes signiﬁcantly regulated in mice undergoing acute DSS-induced
colitis [23] and in inﬂamed intestinal biopsies isolated from
patients displaying severe IBD [24]. In addition, genes
differentially regulated in small intestines (SI) of vitamin Dtreated mice [29] were compared to our own data.

Chromatin immunoprecipitation (ChIP) and ChIPseq
Snap-frozen IECs were thawed on ice, resuspended in 8 ml
of 1% formaldehyde in PBS and incubated at room temperature on a rolling device for 20 min. ChIP was performed
as previously described [17].
Chromatin preparation from formalin-ﬁxed parafﬁnembedded (FFPE) resection specimens from 30 Crohn’s
disease patients was performed following the published
ChromEX-PE technology [46] with slight modiﬁcations.
Brieﬂy, two 20 μm sections were deparafﬁnized and rehydrated. Tissues were incubated in 500 μl of chromatin stabilization buffer (10 mM Tris-HCl, pH 7.5, 10 mM NaCl,
10 mM EDTA, 0.5% Triton X-100, 0.1% sodium deoxycholate, 20% EtOH) at 65 °C overnight and centrifuged at
21,130 x g at 4 °C for 5 min. Tissue pellets were resuspended in 250 μl RIPA buffer (10 mM Tris-HCl, pH 8.0,
140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS)
and lysates were sonicated (20 cycles, 30 sec on/off) using a
Bioruptor Pico sonicator (Diagenode, Inc., Denville, NJ).
Supernatants (chromatin inputs) were collected after
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centrifugation (21,130xg at 4 °C for 5 min) and were incubated with 0.2 μg anti-H3K27ac antibody overnight. After
adding 15 μl of protein G-magnetic beads, the reactions
were further incubated for 3 hours. The beads were extensively washed with ChIP buffer, high salt buffer, LiCl2
buffer, and TE buffer. Bound chromatin was eluted and
reverse-crosslinked at 65 °C overnight. DNA was puriﬁed
using the MinElute PCR puriﬁcation kit (Qiagen, Valencia,
CA) after treatment with RNase A and proteinase K.
Antibody information is listed in Supplementary Table S4
and ChIP-qPCR primers in Supplementary Table S6.
IEC ChIP libraries were prepared using the KAPA Hyper
Prep Kit (KAPABiosystems, Cape Town, South Africa) and
H3K27ac libraries (patient samples) using the ThruPLEX®
DNA-seq Kit V2 (Rubicon Genomics, Ann Arbor, MI,
USA). Library quality was estimated using an Agilent
Bioanalyzer 2100 and samples were sequenced (single-end
50 bp) on a HiSeq4000 (Illumina®, Genome Analysis Core,
Mayo Clinic). Reads were mapped to the murine reference
genome mm9 and analysis was performed as previously
described [17]. Occupancy proﬁles were viewed using
Integrative Genomics Viewer (IGV 2.5.0) [29]. In addition,
to evaluate VDR occupancy, previously published ChIP-seq
data [28] have been compared to our own sequencing
results. H3K27ac libraries were prepared using the ThruPLEX® DNA-seq Kit V2 (Rubicon Genomics, Ann Arbor,
MI, USA) and sequenced to 51 base pairs from both ends
on a HiSeq4000 (Illumina®) in the Mayo Clinic Center for
Individualized Medicine Medical Genomics Facility. The
enrichment was analyzed by targeted real-time PCR in
positive and negative genomic loci. H3K27ac ChIP-seq data
were processed using the internal HiChIP pipeline to generate library-size normalized signal tracks for visualization
and a list of peaks [30]. Brieﬂy, paired-end reads were
mapped to the human reference genome (hg38) by
Burrows-Wheeler Alignment [31] with default settings and
only pairs with at least one of the ends being uniquely
mapped were retained for further analysis. Alignments were
position sorted and duplicates were removed using Picard
tools (https://broadinstitute.github.io/picard/). Peaks were
called using the MACS2 algorithm at FDR ≤ 1%. Differential binding peaks for patients with RNF20/40-associated
gene signatures were called using the DiffBind R package
[32]. Peaks with p value <1e-5 and absolute log2 fold
change >1 were retained as signiﬁcant. ChIP-seq data have
been deposited at ArrayExpress (http://www.ebi.ac.uk/arra
yexpress, accession E-MTAB-9409).

Single cell RNA-seq (scRNA-seq)
Publically available single cell RNA-seq data based on uninﬂamed and inﬂamed intestinal resection specimens isolated
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from Crohn’s disease patients (n = 11) were analyzed as
previously described [20]. Brieﬂy, sequencing data were
aligned to the human reference genome Grch38, and data with
at least 500 unique molecular identiﬁers (UMIs), log10 genes
per UMI >0.8, >250 genes per cell and a mitochondrial ratio
of less than 0.2% were extracted, normalized and integrated
using the seurat package v3.0 in R 4.0.2.

Statistics
Graphs were generated with GraphPad Prism version 8.0.1
(GraphPad Software, Inc.), R version 3.6.2 or 4.0.2 and
Partek® Genomics Suite® software version 7.0 (Copyright©
2018; Partek Inc., St. Louis, MO, USA). Categorical variables were represented as n, and Chi-square test was used
for inter-group comparisons in IBD patient cohorts. Statistical analyses were performed using one-way ANOVA and
subsequent Tukey Post hoc test (α = 0.05, *p ≤ 0.05, **p ≤
0.01, ***p ≤ 0.001).

Data availability
Transcript Proﬁling Sequencing data have been deposited at
ArrayExpress (http://www.ebi.ac.uk/arrayexpress, accession numbers: E-MTAB-9405, E-MTAB-9409).
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